PDCD1 and neoplasm: While the long multi-epitope peptide plus lenalidomide and anti-PD1 vaccine prolonged mouse survival according to the reduced tumor volume, there was no difference in mouse survival with the cocktail of multi-epitope peptides plus lenalidomide and anti-PD1 vaccine.